https://orcid.org/0000-0002-9121-3890
References
- Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer J. 2017;7(6):e577.
- Mohseni M, Uludag H, Brandwein JM. Advances in biology of acute lymphoblastic leukemia (ALL) and therapeutic implications. Am J Blood Res. 2018;8:29–56.
- Inaba H, Mullighan CG. Pediatric acute lymphoblastic leukemia. haematol. 2020;105(11):2524–2539. Online ahead of print.
- Pufall MA. Glucocorticoids and cancer. Adv Exp Med Biol. 2015;872:315–333.
- Wei W, Chen X, Zou Y, et al. Prediction of outcomes by early treatment responses in childhood T-cell acute lymphoblastic leukemia: a retrospective study in China. BMC Pediatr. 2015;15(1):80.
- Li J, Zi Y, Wang W, et al. Long noncoding RNA MEG3 Inhibits cell proliferation and metastasis in chronic myeloid leukemia via targeting miR-184. Oncol Res. 2018;26(2):297–305.
- Yao H, Sun P, Duan M, et al. microRNA-22 can regulate expression of the long non-coding RNA MEG3 in acute myeloid leukemia. Oncotarget. 2017;8(39):65211–65217.
- Lyu Y, Lou J, Yang Y, et al. Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways. Leukemia. 2017;31(12):2543–2551.
- Zhou X, Yuan P, Liu Q, et al. LncRNA MEG3 regulates imatinib resistance in chronic myeloid leukemia via suppressing microRNA-21. Biomol Ther. 2017;25(5):490–496.
- He C, Wang X, Luo J, et al. Long noncoding RNA maternally expressed gene 3 is downregulated, and its insufficiency correlates with poor-risk stratification, worse treatment response, as well as unfavorable survival data in patients with acute myeloid leukemia. Technol Cancer Res Treat. 2020;19:1533033820945815.
- Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937–951.
- Cui L, Li ZG, Chai YH, et al. Outcome of children with newly diagnosed acute lymphoblastic leukemia treated with CCLG-ALL 2008: the first nation-wide prospective multicenter study in China. Am J Hematol. 2018;93(7):913–920.
- Subspecialty Group of Hematology tSoPCMA, Editorial Board CJoP, Subspecialty Group of Hematology the Society of Pediatrics Chinese Medical Association. [Guidelines for the diagnosis and treatment of childhood acute lymphoblastic leukemia]. Zhonghua Er Ke Za Zhi. 2014;52:641–644. Chinese.
- Lauten M, Moricke A, Beier R, et al. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia. Haematologica. 2012;97(7):1048–1056.
- Na L, Ding H, Xing E, et al. Lnc-MEG3 acts as a potential biomarker for predicting increased disease risk, systemic inflammation, disease severity, and poor prognosis of sepsis via interacting with miR-21. J Clin Lab Anal. 2020;34(4):e23123.
- Ratti M, Lampis A, Ghidini M, et al. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol. 2020;15(3):261–278.
- Zimta AA, Tomuleasa C, Sahnoune I, et al. Long non-coding RNAs in myeloid malignancies. Front Oncol. 2019;9:1048.
- Wang Y, Yang X, Sun X, et al. Bone marrow infiltrated Lnc-INSR induced suppressive immune microenvironment in pediatric acute lymphoblastic leukemia. Cell Death Dis. 2018;9(10):1043.
- Wang Y, Wu P, Lin R, et al. LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia. Sci Rep. 2015;5:13749.
- Li Z, Yang L, Liu X, et al. Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21. Biomed Pharmacother. 2018;104:181–192.
- Zhuang W, Ge X, Yang S, et al. Upregulation of lncRNA MEG3 promotes osteogenic differentiation of mesenchymal stem cells from multiple myeloma patients by targeting BMP4 transcription. Stem Cells. 2015;33(6):1985–1997.
- Hao S, Xiang J, Wu DC, et al. Gdf15 regulates murine stress erythroid progenitor proliferation and the development of the stress erythropoiesis niche. Blood Adv. 2019;3(14):2205–2217.
- Zheng Q, Lin Z, Xu J, et al. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN. Cell Death Dis. 2018;9(3):253.
- Hulleman E, Broekhuis MJ, Pieters R, et al. Pyruvate kinase M2 and prednisolone resistance in acute lymphoblastic leukemia. Haematologica. 2009;94(9):1322–1324.
- Oppermann S, Lam AJ, Tung S, et al. Janus and PI3-kinases mediate glucocorticoid resistance in activated chronic leukemia cells. Oncotarget. 2016;7(45):72608–72621.